These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10608043)

  • 1. No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.
    Toss H; Ernofsson M; Wallentin L; Seigbahn A
    J Thromb Thrombolysis; 1998; 5(1):3-7. PubMed ID: 10608043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
    Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
    Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease.
    Ernofsson M; Strekerud F; Toss H; Abildgaard U; Wallentin L; Siegbahn A
    Thromb Haemost; 1998 Mar; 79(3):491-4. PubMed ID: 9531028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels.
    Brugge JM; Tans G; Rosing J; Castoldi E
    Thromb Haemost; 2006 Feb; 95(2):236-42. PubMed ID: 16493484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prothrombinase-based assay for detection of resistance to activated protein C.
    Nicolaes GA; Thomassen MC; van Oerle R; Hamulyak K; Hemker HC; Tans G; Rosing J
    Thromb Haemost; 1996 Sep; 76(3):404-10. PubMed ID: 8883278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies.
    Ku DH; Arkel YS; Paidas MP; Lockwood CJ
    Thromb Haemost; 2003 Dec; 90(6):1074-9. PubMed ID: 14652639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
    Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.
    Lancet; 1999 Aug; 354(9180):701-7. PubMed ID: 10475180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
    Binetti BM; Rotunno C; Tripodi A; Asti D; Semeraro F; Semeraro N; Colucci M
    Thromb Haemost; 2006 Apr; 95(4):606-11. PubMed ID: 16601829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer.
    Paspatis GA; Sfyridaki A; Papanikolaou N; Triantafyllou K; Livadiotaki A; Kapsoritakis A; Lydataki N
    Pathophysiol Haemost Thromb; 2002; 32(1):2-7. PubMed ID: 12214157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial infarction and thromboembolism during pregnancy].
    Härtel D; Sorges E; Carlsson J; Römer V; Tebbe U
    Herz; 2003 May; 28(3):175-84. PubMed ID: 12756475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital and acquired activated protein C resistance.
    Nicolaes GA; Dahlbäck B
    Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.
    Malý M; Vojácek J; Hrabos V; Kvasnicka J; Salaj P; Durdil V
    Physiol Res; 2003; 52(6):719-28. PubMed ID: 14640893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.